Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Discoverie Group PLC Share Issue/Capital Change 2018

Jun 19, 2018

4726_rns_2018-06-19_ae814540-6508-498d-8c7f-56ee806de7b9.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8992R

discoverIE Group plc

19 June 2018

19 June 2018

discoverIE Group plc

ISSUE OF SHARES

discoverIE Group plc (LSE:DSCV, the "Company") announces that application has been made to the UK Listing Authority and the London Stock Exchange for a listing and admission of 18,417 ordinary shares of 5 pence each in the Company ("Shares"). These new Shares are being issued and allotted pursuant to the exercise of options under the Company's 2008 Renewed Long Term Incentive Plan and will rank equally with the existing issued ordinary shares.

Following Admission, which is expected to take place on 25 June 2018, the total number of Shares in issue and voting rights in the Company will be 73,335,194  Shares. There are no Shares held in treasury.

The above figure (73,335,194) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please contact:

discoverIE Group plc

Joanna Harkus Madge: Group Company Secretary 01483 544500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEZKLFFVQFBBBF